ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.